1	Testing	test	VBG	pb=test.01	7	csubj	7:A0=PAG
2	the	the	DT	_	3	det	_
3	levels	level	NNS	_	1	dobj	1:A1=LOC
4	of	of	IN	_	3	prep	_
5	glycated	glycated	VBN	p2=JJ|pb=glycated.01	6	amod	_
6	hemoglobin	hemoglobin	NN	_	4	pobj	5:A1
7	provides	provide	VBZ	pb=provide.01	0	root	_
8	an	an	DT	_	9	det	_
9	assurance	assurance	NN	_	7	dobj	7:A1=PPT
10	to	to	IN	_	7	prep	7:A2=GOL
11	the	the	DT	_	13	det	_
12	healthcare	healthcare	NN	_	13	nn	_
13	practitioner	practitioner	NN	_	10	pobj	_
14	about	about	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	patient	patient	NN	_	20	poss	_
17	's	's	POS	_	16	possessive	_
18	blood	blood	NN	_	19	nn	_
19	glucose	glucose	NN	_	20	nn	_
20	level	level	NN	_	14	pobj	_
21	.	.	.	_	7	punct	_

1	This	this	DT	_	2	det	_
2	test	test	NN	_	5	nsubjpass	5:A1=PPT
3	can	can	MD	_	5	aux	5:AM-MOD
4	be	be	VB	_	5	auxpass	_
5	used	use	VBN	pb=use.01	0	root	_
6	for	for	IN	_	5	prep	5:A2=PRP
7	diagnosis	diagnosis	NN	_	6	pobj	_
8	and	and	CC	_	7	cc	_
9	monitoring	monitoring	NN	_	7	conj	_
10	of	of	IN	_	9	prep	_
11	hemoglobin	hemoglobin	NN	p2=JJ	13	nn	_
12	A1c	a1c	NNP	p2=JJ	13	nn	_
13	levels	level	NNS	_	10	pobj	_
14	in	in	IN	_	13	prep	_
15	diabetic	diabetic	JJ	_	16	amod	_
16	patients	patient	NNS	_	14	pobj	_
17	.	.	.	_	5	punct	_

1	Since	since	IN	_	4	mark	_
2	A1C	a1c	NNP	p2=JJ	3	nn	_
3	test	test	NN	_	4	nsubj	4:A2=PAG
4	reflects	reflect	VBZ	pb=reflect.01	20	advcl	20:AM-CAU
5	the	the	DT	_	7	det	_
6	average	average	JJ	_	7	amod	_
7	amount	amount	NN	_	4	dobj	4:A1=PPT
8	of	of	IN	_	7	prep	_
9	glucose	glucose	NN	_	8	pobj	_
10	for	for	IN	_	9	prep	_
11	the	the	DT	_	16	det	_
12	past	past	JJ	_	16	amod	_
13	2	0	CD	_	15	number	_
14	to	to	TO	p2=IN	15	quantmod	_
15	3	0	CD	_	16	num	_
16	months	month	NNS	_	10	pobj	_
17	,	,	,	_	20	punct	_
18	it	it	PRP	_	20	nsubjpass	20:A1=PPT;22:A1=PPT
19	is	be	VBZ	_	20	auxpass	_
20	opined	opine	VBN	p2=JJ|pb=opine.01	0	root	_
21	to	to	TO	_	22	aux	_
22	be	be	VB	pb=be.01	20	xcomp	20:C-A1
23	more	more	RBR	_	24	advmod	_
24	reliable	reliable	JJ	_	22	acomp	22:A2=PRD
25	than	than	IN	_	24	prep	_
26	conventional	conventional	JJ	_	29	amod	_
27	blood	blood	NN	_	28	nn	_
28	glucose	glucose	NN	_	29	nn	_
29	test	test	NN	_	25	pobj	_
30	.	.	.	_	20	punct	_

1	Physicians	physician	NNS	p2=NNPS	4	nsubj	4:A0=PAG
2	are	be	VBP	_	4	aux	_
3	increasingly	increasingly	RB	_	4	advmod	4:AM-ADV
4	prescribing	prescribe	VBG	p2=JJ|pb=prescribe.02	0	root	_
5	HbA1c	hba1c	NNP	p2=JJ	6	nn	_
6	test	test	NN	p2=VB	4	dobj	4:A1=PPT
7	to	to	IN	_	4	prep	4:A2=PRP
8	their	their	PRP$	_	9	poss	_
9	patients	patient	NNS	_	7	pobj	12:A0=PAG
10	which	which	WDT	_	12	nsubj	12:R-A0
11	will	will	MD	_	12	aux	12:AM-MOD
12	lead	lead	VB	pb=lead.03	9	rcmod	_
13	to	to	IN	_	12	prep	12:A2=PRD
14	an	an	DT	_	15	det	_
15	increase	increase	NN	_	13	pobj	_
16	in	in	IN	_	15	prep	_
17	the	the	DT	_	19	det	_
18	test	test	NN	_	19	nn	_
19	volume	volume	NN	_	16	pobj	_
20	.	.	.	_	4	punct	_

1	Moreover	moreover	RB	_	7	advmod	7:AM-DIS
2	,	,	,	_	7	punct	_
3	rising	rise	VBG	pb=rise.01	6	amod	_
4	diabetes	diabetes	NN	p2=FW	6	nn	_
5	incidence	incidence	NN	_	6	nn	_
6	rate	rate	NN	_	7	nsubj	3:A1;7:A1=PPT
7	is	be	VBZ	pb=be.01	0	root	_
8	a	a	DT	_	10	det	_
9	major	major	JJ	_	10	amod	_
10	driver	driver	NN	_	7	attr	7:A2=PRD
11	for	for	IN	_	10	prep	_
12	the	the	DT	_	15	det	_
13	HbA1c	hba1c	NNP	p2=JJ	15	nn	_
14	testing	testing	NN	_	15	nn	_
15	market	market	NN	_	11	pobj	_
16	.	.	.	_	7	punct	_

1	With	with	IN	_	18	prep	18:AM-ADV
2	growing	grow	VBG	pb=grow.01	3	amod	_
3	awareness	awareness	NN	_	1	pobj	2:A1=PPT
4	about	about	IN	_	3	prep	_
5	prevention	prevention	NN	_	4	pobj	_
6	and	and	CC	_	5	cc	_
7	management	management	NN	_	5	conj	_
8	of	of	IN	_	5	prep	_
9	diabetes	diabetes	NN	p2=NNS	8	pobj	_
10	,	,	,	_	18	punct	_
11	the	the	DT	_	12	det	_
12	demand	demand	NN	_	18	nsubj	18:A1
13	for	for	IN	_	12	prep	_
14	HbA1c	hba1c	NNP	p2=JJ	16	nn	_
15	testing	testing	NN	p2=VBG	16	nn	_
16	devices	device	NNS	_	13	pobj	_
17	will	will	MD	_	18	aux	18:AM-MOD
18	rise	rise	VB	pb=rise.01	0	root	_
19	rapidly	rapidly	RB	_	18	advmod	18:A2=EXT
20	especially	especially	RB	_	21	advmod	_
21	in	in	IN	_	18	prep	18:AM-LOC
22	the	the	DT	_	25	det	_
23	Asia	asia	NNP	_	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	Pacific	pacific	NNP	_	21	pobj	_
26	,	,	,	_	25	punct	_
27	Latin	latin	NNP	_	28	nn	_
28	America	america	NNP	_	25	conj	_
29	,	,	,	_	28	punct	_
30	Middle	middle	NNP	_	31	nn	_
31	East	east	NNP	p2=JJ	28	conj	_
32	and	and	CC	_	31	cc	_
33	African	african	JJ	_	34	amod	_
34	regions	region	NNS	_	31	conj	_
35	.	.	.	_	18	punct	_

1	Moreover	moreover	RB	_	14	advmod	14:AM-DIS
2	,	,	,	_	14	punct	_
3	advent	advent	NN	_	14	nsubj	14:A0=PAG
4	of	of	IN	_	3	prep	_
5	these	these	DT	_	6	det	_
6	devices	device	NNS	_	4	pobj	_
7	for	for	IN	_	3	prep	_
8	the	the	DT	_	9	det	_
9	diagnosis	diagnosis	NN	_	7	pobj	_
10	of	of	IN	_	9	prep	_
11	diabetes	diabetes	NN	p2=NNS	10	pobj	_
12	will	will	MD	_	14	aux	14:AM-MOD
13	further	far	RB	p2=RBR	14	advmod	14:AM-EXT
14	bolster	bolster	VB	pb=bolster.01	0	root	_
15	the	the	DT	_	16	det	_
16	demand	demand	NN	_	14	dobj	14:A1=PPT
17	for	for	IN	_	16	prep	_
18	these	these	DT	_	19	det	_
19	devices	device	NNS	_	17	pobj	_
20	in	in	IN	_	16	prep	_
21	future	future	NN	_	20	pobj	_
22	.	.	.	_	14	punct	_

1	For	for	IN	_	38	prep	38:AM-DIS
2	instance	instance	NN	_	1	pobj	_
3	,	,	,	_	4	punct	_
4	approval	approval	NN	_	38	ccomp	_
5	for	for	IN	_	4	prep	_
6	the	the	DT	_	14	det	_
7	COBAS	cobas	NNP	p2=NNPS	8	nn	_
8	INTEGRA	integra	NNP	_	14	nn	_
9	800	0	CD	_	14	num	_
10	Tina	tina	NNP	_	12	hmod	_
11	-	-	HYPH	p2=.	12	hyph	_
12	quant	quant	JJ	p2=NNP	14	amod	_
13	HbA1cDx	hba1cdx	NNP	_	14	nn	_
14	assay	assay	NN	p2=NNP	5	pobj	_
15	,	,	,	_	38	punct	_
16	in	in	IN	_	38	prep	38:AM-TMP
17	2013	0	CD	_	16	pobj	_
18	and	and	CC	_	8	cc	_
19	Abbott	abbott	NNP	_	29	poss	_
20	's	's	POS	_	19	possessive	_
21	ARCHITECT	architect	NNP	_	22	nn	_
22	Clinical	clinical	NNP	p2=JJ	29	nn	_
23	Chemistry	chemistry	NNP	_	25	nn	_
24	Hemoglobin	hemoglobin	NNP	_	25	nn	_
25	A1c	a1c	NNP	_	29	nn	_
26	(	(	-LRB-	_	27	punct	_
27	HbA1c	hba1c	NNP	_	25	appos	_
28	)	)	-RRB-	_	27	punct	_
29	test	test	NN	_	38	nsubj	30:A1=PPT;38:A1=PPT
30	approved	approve	VBN	p2=VBD|pb=approve.01	29	partmod	_
31	in	in	IN	_	30	prep	30:AM-TMP
32	2014	0	CD	_	31	pobj	_
33	for	for	IN	_	30	prep	30:A2=PRD
34	the	the	DT	_	35	det	_
35	diagnosis	diagnosis	NN	_	33	pobj	_
36	of	of	IN	_	35	prep	_
37	diabetes	diabetes	NN	p2=NNS	36	pobj	_
38	were	be	VBD	pb=be.01	0	root	_
39	the	the	DT	_	41	det	_
40	major	major	JJ	_	41	amod	_
41	steps	step	NNS	_	38	attr	38:A2=PRD
42	in	in	IN	_	41	prep	_
43	the	the	DT	_	47	det	_
44	hemoglobin	hemoglobin	NN	_	47	nn	_
45	A1c	a1c	NNP	p2=JJ	47	nn	_
46	testing	testing	NN	p2=VBG	47	nn	_
47	industry	industry	NN	_	42	pobj	_
48	.	.	.	_	38	punct	_

1	With	with	IN	_	8	prep	8:AM-MNR
2	this	this	DT	_	4	det	_
3	diagnostic	diagnostic	JJ	_	4	amod	_
4	tools	tool	NNS	_	1	pobj	_
5	,	,	,	_	8	punct	_
6	physicians	physician	NNS	_	8	nsubj	8:A0=PAG
7	can	can	MD	_	8	aux	8:AM-MOD
8	combat	combat	VB	pb=combat.01	0	root	_
9	the	the	DT	_	11	det	_
10	rising	rise	VBG	p2=JJ|pb=rise.01	11	amod	_
11	incidence	incidence	NN	_	8	dobj	8:A1=COM;10:A1
12	of	of	IN	_	11	prep	_
13	diabetes	diabetes	NN	p2=NNS	12	pobj	_
14	with	with	IN	_	8	prep	_
15	timely	timely	JJ	_	18	amod	_
16	and	and	CC	_	15	cc	_
17	appropriate	appropriate	JJ	_	15	conj	_
18	actions	action	NNS	_	14	pobj	_
19	in	in	IN	_	18	prep	_
20	identifying	identify	VBG	pb=identify.01	19	pcomp	_
21	and	and	CC	_	20	cc	_
22	managing	manage	VBG	pb=manage.01	20	conj	_
23	diabetes	diabetes	NN	p2=NNS	22	dobj	22:A1=PPT
24	.	.	.	_	8	punct	_

1	Based	base	VBN	_	16	prep	16:AM-ADV
2	on	on	IN	_	1	prep	_
3	the	the	DT	_	6	det	_
4	end	end	NN	_	6	hmod	_
5	-	-	HYPH	p2=,	6	hyph	_
6	use	use	NN	_	2	pobj	_
7	,	,	,	_	16	punct	_
8	the	the	DT	_	14	det	_
9	global	global	JJ	_	10	amod	_
10	hemoglobin	hemoglobin	NN	_	14	nn	_
11	A1c	a1c	NNP	p2=JJ	14	nn	_
12	testing	testing	NN	_	13	nn	_
13	devices	device	NNS	_	14	nn	_
14	market	market	NN	_	16	nsubjpass	16:A1=PPT
15	is	be	VBZ	_	16	auxpass	_
16	categorized	categorize	VBN	pb=categorize.01	0	root	_
17	into	into	IN	_	16	prep	16:A2=GOL
18	two	#crd#	CD	_	19	num	_
19	segments	segment	NNS	_	17	pobj	_
20	namely	namely	RB	_	21	advmod	21:AM-MNR
21	laboratory	laboratory	VBP	p2=NN|pb=laboratory.01	16	advcl	16:AM-ADV
22	testing	testing	NN	p2=VBG	33	nn	_
23	and	and	CC	_	22	cc	_
24	point	point	NN	_	28	hmod	_
25	-	-	HYPH	_	28	hyph	_
26	of	of	IN	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	care	care	NN	_	22	conj	_
29	(	(	-LRB-	_	28	punct	_
30	POC	poc	NNP	p2=NN	28	appos	_
31	)	)	-RRB-	_	28	punct	_
32	testing	testing	NN	p2=VBG	33	nn	_
33	devices	device	NNS	_	21	dobj	21:A1
34	.	.	.	_	16	punct	_

1	Laboratory	laboratory	NN	p2=JJ	2	nn	_
2	testing	testing	NN	_	3	nn	_
3	devices	device	NNS	_	4	nsubj	4:A0=PAG
4	held	hold	VBD	pb=hold.01	0	root	_
5	the	the	DT	_	7	det	_
6	majority	majority	NN	_	7	nn	_
7	share	share	NN	_	4	dobj	4:A1=PPT
8	of	of	IN	_	7	prep	_
9	the	the	DT	_	10	det	_
10	market	market	NN	_	8	pobj	_
11	in	in	IN	_	4	prep	4:AM-TMP
12	2012	0	CD	_	11	pobj	_
13	,	,	,	_	4	punct	_
14	while	while	IN	_	27	mark	_
15	the	the	DT	_	17	det	_
16	global	global	JJ	_	17	amod	_
17	market	market	NN	_	27	nsubjpass	27:A1=PPT;29:A1=PPT
18	for	for	IN	_	17	prep	_
19	point	point	NN	_	23	hmod	_
20	-	-	HYPH	_	23	hyph	_
21	of	of	IN	_	23	hmod	_
22	-	-	HYPH	_	23	hyph	_
23	care	care	NN	_	24	nn	_
24	testing	testing	NN	_	25	nn	_
25	devices	device	NNS	_	18	pobj	_
26	is	be	VBZ	_	27	auxpass	_
27	expected	expect	VBN	pb=expect.01	4	advcl	4:AM-ADV
28	to	to	TO	_	29	aux	_
29	grow	grow	VB	pb=grow.01	27	xcomp	27:C-A1
30	at	at	IN	_	29	prep	29:A2=EXT
31	a	a	DT	_	33	det	_
32	faster	fast	JJR	_	33	amod	_
33	pace	pace	NN	_	30	pobj	_
34	during	during	IN	_	29	prep	29:AM-TMP
35	the	the	DT	_	37	det	_
36	forecast	forecast	NN	p2=JJ	37	nn	_
37	period	period	NN	_	34	pobj	_
38	.	.	.	_	4	punct	_

1	Based	base	VBN	_	13	prep	13:AM-ADV
2	on	on	IN	_	1	prep	_
3	technologies	technology	NNS	_	2	pobj	_
4	,	,	,	_	13	punct	_
5	the	the	DT	_	10	det	_
6	hemoglobin	hemoglobin	NN	_	10	nn	_
7	A1c	a1c	NNP	p2=JJ	10	nn	_
8	testing	testing	NN	_	9	nn	_
9	devices	device	NNS	p2=VBZ	10	nn	_
10	market	market	NN	_	13	nsubjpass	13:A1=PPT
11	is	be	VBZ	_	13	auxpass	_
12	further	far	RB	p2=RBR	13	advmod	13:AM-EXT
13	categorized	categorize	VBN	pb=categorize.01	0	root	_
14	into	into	IN	_	13	prep	13:A2=GOL
15	five	#crd#	CD	_	16	num	_
16	segments	segment	NNS	_	14	pobj	_
17	,	,	,	_	16	punct	_
18	namely	namely	RB	_	16	advmod	_
19	,	,	,	_	16	punct	_
20	ion	ion	NN	p2=JJ	22	hmod	_
21	-	-	HYPH	_	22	hyph	_
22	exchange	exchange	NN	_	23	nn	_
23	HPLC	hplc	NNP	p2=NN	16	appos	_
24	,	,	,	_	23	punct	_
25	immunoassay	immunoassay	NN	p2=RB	23	conj	_
26	,	,	,	_	25	punct	_
27	boronate	boronate	NN	p2=VB	28	nn	_
28	affinity	affinity	NN	_	29	nn	_
29	chromatography	chromatography	NN	p2=JJ	25	conj	_
30	,	,	,	_	29	punct	_
31	direct	direct	JJ	p2=VB	33	amod	_
32	enzymatic	enzymatic	JJ	p2=NN	33	amod	_
33	assay	assay	NN	_	29	conj	_
34	and	and	CC	_	33	cc	_
35	others	other	NNS	_	33	conj	_
36	.	.	.	_	13	punct	_

1	The	the	DT	_	5	det	_
2	boronate	boronate	JJ	p2=NN	5	amod	_
3	affinity	affinity	NN	_	5	nn	_
4	chromatography	chromatography	NN	p2=WRB	5	nn	_
5	market	market	NN	_	8	nsubj	8:A1=PPT
6	will	will	MD	_	8	aux	8:AM-MOD
7	be	be	VB	_	8	aux	_
8	growing	grow	VBG	pb=grow.01	0	root	_
9	at	at	IN	_	8	prep	8:A2=EXT
10	a	a	DT	_	12	det	_
11	faster	fast	JJR	_	12	amod	_
12	pace	pace	NN	_	9	pobj	_
13	during	during	IN	_	8	prep	8:AM-TMP
14	the	the	DT	_	16	det	_
15	forecast	forecast	NN	p2=JJ	16	nn	_
16	period	period	NN	_	13	pobj	_
17	as	as	IN	_	20	mark	_
18	this	this	DT	_	19	det	_
19	technology	technology	NN	_	20	nsubj	20:A0=PAG;29:A1=PPT
20	has	have	VBZ	pb=have.03	8	advcl	8:AM-ADV
21	no	no	DT	_	22	det	_
22	interference	interference	NN	_	20	dobj	20:A1=PPT
23	from	from	IN	_	22	prep	_
24	hemoglobin	hemoglobin	NN	p2=FW	25	nn	_
25	variants	variant	NNS	p2=VBZ	23	pobj	_
26	and	and	CC	_	20	cc	_
27	is	be	VBZ	_	29	auxpass	_
28	also	also	RB	_	29	advmod	29:AM-ADV
29	used	use	VBN	pb=use.01	20	conj	_
30	in	in	IN	_	29	prep	29:AM-LOC
31	both	both	DT	p2=CC	32	det	_
32	laboratory	laboratory	NN	_	30	pobj	_
33	as	as	RB	_	35	advmod	_
34	well	well	RB	_	35	advmod	_
35	as	as	IN	_	32	cc	_
36	point	point	NN	p2=JJ	40	hmod	_
37	-	-	HYPH	_	40	hyph	_
38	of	of	IN	_	40	hmod	_
39	-	-	HYPH	_	40	hyph	_
40	care	care	NN	_	41	nn	_
41	testing	testing	NN	_	32	conj	_
42	.	.	.	_	8	punct	_

1	Healthcare	healthcare	NNP	p2=NN	2	nn	_
2	practitioners	practitioner	NNS	_	4	nsubj	4:A0=PAG
3	are	be	VBP	_	4	aux	_
4	recommending	recommend	VBG	pb=recommend.01	0	root	_
5	the	the	DT	_	6	det	_
6	use	use	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	devices	device	NNS	_	7	pobj	10:A0=PAG
9	which	which	WDT	_	10	nsubj	10:R-A0
10	offer	offer	VBP	pb=offer.01	8	rcmod	_
11	least	least	JJS	p2=RBS	12	advmod	_
12	variant	variant	JJ	p2=NN	13	amod	_
13	interference	interference	NN	_	10	dobj	10:A1=PPT
14	and	and	CC	_	13	cc	_
15	this	this	DT	_	17	nsubj	17:A0=PAG
16	would	would	MD	_	17	aux	17:AM-MOD
17	elevate	elevate	VB	pb=elevate.01	4	ccomp	_
18	the	the	DT	_	19	det	_
19	demand	demand	NN	_	17	dobj	17:A1=PPT
20	for	for	IN	_	19	prep	_
21	boronate	boronate	NN	p2=JJ	22	nn	_
22	affinity	affinity	NN	_	23	nn	_
23	chromatography	chromatography	NN	_	20	pobj	_
24	in	in	IN	_	23	prep	_
25	HbA1c	hba1c	NNP	p2=JJ	26	nn	_
26	testing	testing	NN	_	24	pobj	_
27	.	.	.	_	4	punct	_

1	F.	f.	NNP	p2=LS	9	nn	_
2	Hoffmann	hoffmann	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	La	la	NNP	_	9	nn	_
5	Roche	roche	NNP	_	6	nn	_
6	Ltd.	ltd.	NNP	_	7	nn	_
7	Zeitverzögerung	zeitverzögerung	NNP	_	9	nn	_
8	der	der	NNP	p2=NN	9	nn	_
9	Kursdaten	kursdaten	NNP	p2=NNPS	0	root	_
10	:	:	:	_	9	punct	_
11	Deutsche	deutsche	NNP	_	14	nn	_
12	Börsen	börsen	NNP	_	14	nn	_
13	+15	+15	NNP	p2=POS	14	nn	_
14	Min	min	NNP	_	9	appos	_
15	.	.	.	_	9	punct	_

1	NASDAQ	nasdaq	NNP	_	3	nn	_
2	+15	+15	NNP	p2=CD	3	nn	_
3	Min	min	NNP	_	0	root	_
4	.	.	.	_	3	punct	_

1	NYSE	nyse	NNP	p2=NN	3	nn	_
2	+20	+20	NNP	p2=CD	3	nn	_
3	Min	min	NNP	_	0	root	_
4	.	.	.	_	3	punct	_

1	AMEX	amex	NNP	_	3	nn	_
2	+20	+20	NNP	p2=CD	3	nn	_
3	Min	min	NNP	_	0	root	_
4	.	.	.	_	3	punct	_

1	Dow	dow	NNP	_	2	nn	_
2	Jones	jones	NNP	_	4	nn	_
3	+15	+15	NNP	p2=IN	4	nn	_
4	Min	min	NNP	_	0	root	_
5	.	.	.	_	4	punct	_

